ArticleInternational cancer conference journal2025

A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma.

Fumihiko Urabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.